Evaluation of Left Atrial Function in Patients with Paroxysmal Atrial Fibrillation Using Left Atrial Automatic Myocardial Functional Imaging Ultrasonography
Table 1
Comparison of baseline data between control group and NVPAF group.
Clinical characteristics
Control (n = 60)
NVPAF (n = 80)
value
Male gender, n (%)
35 (58.3)
50 (62.5)
0.203
Age (years) (mean ± SD)
58.8 ± 5.2
61.59 ± 9.4
0.420
LVEF (%) (mean ± SD)
60.48 ± 6.89
58.70 ± 8.23
0.176
BMI (kg/m2) (mean ± SD)
22.69 ± 2.77
23.57 ± 2.58
0.561
Hypertension, n (%)
19 (31.7)
38 (47.5)
0.059
Diabetes, n (%)
6 (10.0)
15 (18.8)
0.151
Hyperlipidemia, n (%)
8 (13.3)
13 (16.3)
0.632
Mitral regurgitation, n (%)
None
10 (16.7)
7 (11.7)
0.099
Mild
40 (66.6)
58 (72.5)
Moderate
10 (16.7)
15 (18.8)
Severe
0
0
Mean ± SD, the values are presented as the mean ± standard deviation; the remaining values represent the number and proportion of patients. NVPAF, nonvalvular paroxysmal atrial fibrillation; BMI, body mass index; LVEF, left ventricular ejection fraction.
